Angelini Ventures logo

Angelini Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Series A

Neumirna Therapeutics is a biotech company developing RNA-based therapies, focusing on an Antisense Oligonucleotide treatment for drug-resistant epilepsy.

Series A
$20.7M
01/08/2025
Article

Aptadir Therapeutics is a biotech company developing RNA-based inhibitors to treat Myelodysplastic Syndrome (MDS).

Seed
$1.6M
09/24/2024
Article

Freya Biosciences is a biotech company advancing women's reproductive health through the development of vaginal microbial immunotherapeutics for infertility associated with dysbiotic vaginal microbiota in patients undergoing assisted reproductive technology.

Series A
$38M
12/12/2023
Article